Unknown

Dataset Information

0

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma.


ABSTRACT: Hepatocellular carcinoma (HCC) is a major health concern worldwide, and its incidence is increasing steadily. Recently, the MAPK/ERK signaling pathway in HCC has gained renewed attention from basic and clinical researchers. The MAPK/ERK signaling pathway is activated in more than 50% of human HCC cases; however, activating mutations in RAS and RAF genes are rarely found in HCC, which are major genetic events leading to the activation of the MAPK/ERK signaling pathway in other cancers. This suggests that there is an alternative mechanism behind the activation of the signaling pathway in HCC. Here, we will review recent advances in understanding the cellular and molecular mechanisms involved in the activation of the MAPK/ERK signaling pathway and discuss potential therapeutic strategies targeting the signaling pathway in the context of HCC.

SUBMITTER: Moon H 

PROVIDER: S-EPMC8234271 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5355334 | biostudies-literature
| S-EPMC9859789 | biostudies-literature
| S-EPMC6249243 | biostudies-literature
| S-EPMC8128908 | biostudies-literature
| S-EPMC4081602 | biostudies-literature
| S-EPMC6053381 | biostudies-literature
| S-EPMC8163843 | biostudies-literature
| S-EPMC7385585 | biostudies-literature
| S-EPMC5836448 | biostudies-literature
| S-EPMC5564549 | biostudies-literature